journal article·2025-01-24

Covalent Organic Frameworks with Fe/Co Single-Atom Nanozyme for Alendronate Sodium Detection

Jingcheng Cao, Jie Lv, Yingchao Yin, Qingqing Bai, Meng Li, Zhiyong Hou

ACS Applied Nano Materials· Volume 8· Issue 3
Publisher page

Abstract

Constructing nanozyme-based single atoms with exposed metal-Nx catalytic sites for alendronate sodium (ALDS) tablet quality control is a complex and uncommon task. Herein, we presented an innovative colorimetric assay to detect ALDS utilizing carbon-supported Fe/Co dual-atom nanozymes (Fe/Co SA -NCs) derived from a precursor of porphyrin covalent organic frameworks (COFs). The Fe/Co SA -NC nanozymes, featuring an Fe–N 5 active site and electronic interactions between Fe and Co, exhibited enhanced peroxidase-like activity. Experimental findings and theoretical calculations elucidated that the superior activity of Fe/Co SA -NCs stemmed from the synergistic effect of the dual atoms, which boosted substrate adsorption and reduced the reaction barrier. When integrated with ALDS and Fe/Co SA -NCs, the peroxidase-like activity of Fe/Co SA -NCs could be inhibited due to ALDS-Fe 3+ coordination. Leveraging this mechanism, a rapid and selective colorimetric method was developed for detecting ALDS. The Fe/Co SA -NC sensor showed a detection limit of 0.96 μM for ALDS in phosphate buffer, surpassing traditional techniques in terms of efficiency, accuracy, and simplicity. Moreover, the system was successfully utilized to control the pharmaceutical quality of ALDS and to determine ALDS in urine samples. This work opens a powerful avenue for developing efficient dual-atom nanozymes from COFs and expands the potential applications of nanozyme clinical pharmacy.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Advanced Nanomaterials in Catalysis · Electrochemical sensors and biosensors · Molecular Sensors and Ion Detection

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Orthopaedic Surgery, Third Hospital of Hebei Medical University, No.139 Ziqiang Road, Shijiazhuang 050051, China

Orthopaedic Research Institute of Hebei Province, Third Hospital of Hebei Medical University, Shijiazhuang 050051, China

College of Pharmacy, Key Laboratory of Innovative Drug Development and Evaluation, Hebei Medical University, Shijiazhuang 050017, China

Postdoctoral Mobile Station of Basic Medicine, Hebei Medical University, Shijiazhuang 050017, China

Funding

Natural Science Foundation of Hebei Province · Hebei Provincial?Postdoctoral Science?Foundation · Hebei Medical University · Department of Education of Hebei Province · Central Guidance on Local Science and Technology Development Fund of Hebei Province

References (48)

Show source-provided references
1. 10.1016/j.bone.2020.11541110.1016/j.bone.2020.115411 ↗
2. 10.25259/ASJO-2022-27-(371)10.25259/ASJO-2022-27-(371) ↗
3. 10.1038/s41413-022-00217-w10.1038/s41413-022-00217-w ↗
4. 10.1021/acs.jmedchem.0c0129210.1021/acs.jmedchem.0c01292 ↗
5. 10.1016/j.etap.2016.01.01510.1016/j.etap.2016.01.015 ↗
6. 10.1080/10717544.2022.216409410.1080/10717544.2022.2164094 ↗
7. 10.1038/s41574-023-00866-910.1038/s41574-023-00866-9 ↗
8. 10.1039/C9TB01857C10.1039/C9TB01857C ↗
9. 10.1016/j.chroma.2020.46180910.1016/j.chroma.2020.461809 ↗
10. 10.1016/j.snb.2018.04.12710.1016/j.snb.2018.04.127 ↗
11. 10.1016/j.chroma.2014.09.01610.1016/j.chroma.2014.09.016 ↗
12. 10.1016/j.jpba.2005.06.02510.1016/j.jpba.2005.06.025 ↗
13. 10.1016/j.talanta.2004.03.04410.1016/j.talanta.2004.03.044 ↗
14. 10.1016/j.trac.2021.11632010.1016/j.trac.2021.116320 ↗
15. 10.1016/j.ccr.2021.21406110.1016/j.ccr.2021.214061 ↗
16. 10.1039/D4CS00328D10.1039/D4CS00328D ↗
17. 10.1016/j.chroma.2008.12.05110.1016/j.chroma.2008.12.051 ↗
18. 10.1016/j.ccr.2024.21579910.1016/j.ccr.2024.215799 ↗
19. 10.1016/j.talanta.2020.12172210.1016/j.talanta.2020.121722 ↗
20. 10.1016/j.colsurfb.2021.11195310.1016/j.colsurfb.2021.111953 ↗
21. 10.1016/j.saa.2022.12175210.1016/j.saa.2022.121752 ↗
22. 10.1016/j.pmatsci.2022.10095910.1016/j.pmatsci.2022.100959 ↗
23. 10.1021/acs.chemrev.1c0015810.1021/acs.chemrev.1c00158 ↗
24. 10.1039/D0SC03522J10.1039/D0SC03522J ↗
25. 10.1038/s41929-021-00609-x10.1038/s41929-021-00609-x ↗
26. 10.1002/aenm.20210356410.1002/aenm.202103564 ↗
27. 10.1021/accountsmr.1c0026410.1021/accountsmr.1c00264 ↗
28. 10.1002/smll.20210609110.1002/smll.202106091 ↗
29. 10.1021/jacs.0c0972710.1021/jacs.0c09727 ↗
30. 10.1002/advs.20220623910.1002/advs.202206239 ↗
31. 10.1021/acsami.0c0602210.1021/acsami.0c06022 ↗
32. 10.1038/s43586-022-00181-z10.1038/s43586-022-00181-z ↗
33. 10.1021/jacs.2c0773310.1021/jacs.2c07733 ↗
34. 10.1016/j.apsusc.2021.14922810.1016/j.apsusc.2021.149228 ↗
35. 10.1038/s41467-022-35736-x10.1038/s41467-022-35736-x ↗
36. 10.1016/j.pmatsci.2023.10108910.1016/j.pmatsci.2023.101089 ↗
37. 10.1016/j.apcatb.2024.12432010.1016/j.apcatb.2024.124320 ↗
38. 10.1002/adma.20240553310.1002/adma.202405533 ↗
39. 10.1016/j.ensm.2021.12.02910.1016/j.ensm.2021.12.029 ↗
40. 10.1021/acs.analchem.3c0107010.1021/acs.analchem.3c01070 ↗
41. 10.1039/D0AN01383H10.1039/D0AN01383H ↗
42. 10.1016/j.cej.2024.15275310.1016/j.cej.2024.152753 ↗
43. 10.1021/acssuschemeng.1c0797510.1021/acssuschemeng.1c07975 ↗
44. 10.1186/1752-153X-6-2510.1186/1752-153X-6-25 ↗
45. 10.1002/bio.362210.1002/bio.3622 ↗
46. 10.1016/j.talanta.2004.03.04410.1016/j.talanta.2004.03.044 ↗
47. 10.1016/j.jallcom.2017.05.01610.1016/j.jallcom.2017.05.016 ↗
48. 10.3390/molecules2616509310.3390/molecules26165093 ↗